Concepedia

V. Conde

VC

Statistics

Publications

4

Citations

61

H-Index

4

Active since

2014

Affiliations

Hospital Universitario Virgen de las Nieves(Current)

Institut d'Investigació Biomédica de Bellvitge

University of Córdoba

Hospital Clínico San Carlos

Instituto de Salud Carlos III

V. Conde is an author at Hospital Universitario Virgen de las Nieves specializing in surgical oncology, cancer therapeutics, and oncology.

Top concepts

Publications per year

2014–2021

4

Publications

4

Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy

María Belén García‐Ortega, Alberto Mesa, Elisa L. J. Moya et al. · Cancers · 2020 · 20 citations · Full text

Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02

Fernando Rivera, Bartomeu Massutí, Matilde Salcedo et al. · Cancer Chemotherapy and Pharmacology · 2014 · 17 citations · Full text

, , +8

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

Albert Abad, Eva Martinez‐Balibrea, José María Viéitez et al. · Annals of Oncology · 2017 · 13 citations · Full text

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer

Isabel Blancas, C Olier, V. Conde et al. · Scientific Reports · 2021 · 11 citations · Full text

1–4 of 4